ebook Munafa Stock Market Course + Intraday & FNO calls  

       

532523 announcements Biocon Ltd. announcements and dividends declared BSE

Biocon Ltd. Complete list of announcements declared & dividend announcements by Biocon Ltd. 532523

Biocon Ltd. 532523 listed on BSE and deals in

Announcements and dividends declared by Biocon Ltd. 532523

Biocon arm gets USFDA nod for chronic heart failure drug
Biocon Pharma, a wholly owned subsidiary of Biocon, has received approval of its ANDA for Sacubitril/Valsartan Tablets, from the U.S Food and Drug Administration (US FDA).
Announcement as on 02 September 2024

Biocon unit gets USFDA nod for generic drug
Biocon Pharma has received approval of its ANDA for Sacubitril/Valsartan Tablets, in 24 mg/26 mg, 49 mg/51 mg and 97 mg/103 mg strengths, from the US Food and Drug Administration (USFDA), the company said in a regulatory filing. Sacubitril and valsartan co
Announcement as on 01 September 2024

Biocon subsidiary gets USFDA nod for generic drug for chronic heart failure
Biotechnology firm Biocon said its subsidiary has received approval from the US health regulator to market a generic medication to treat chronic heart failure. Biocon Pharma has received approval of its ANDA for Sacubitril/Valsartan Tablets, in 24 mg/26 mg
Announcement as on 01 September 2024

Biocon Biologics secures deal with Janssen to launch biosimilar Bmab 1200
Agreement clears way for Indian company to launch treatment in Europe, Canada and other markets
Announcement as on 29 August 2024

Biocon settles with Janssen to commercialise biosimilar products in Europe, Canada, Japan
Biocon Biologics has entered into a settlement and licence agreement with Janssen Biotech Inc, Janssen Sciences Ireland, and Johnson & Johnson to launch Bmab 1200, a biosimilar to Stelara, in Europe, the UK, Canada, and Japan. This deal resolves patent
Announcement as on 29 August 2024

Announcements by Biocon Ltd. first page | Next page | Prev page |

532523 Biocon Ltd. current price & indicator signals

Moving Averages for Biocon Ltd.

  • 5Day Average: 365.67
  • 12Day Average: 370.91
  • 20Day Average: 378.15
  • 50Day Average: 376.76
  • 100Day Average: 384.53
  • 150Day Average: 376.1
  • 200Day Average: 374.54

532523 Indicators & signals

Indicator MACD (12,26,9)

370.02, 375.56, -2.64
Indicator MACD is in negative zone

Indicator ADX (14)

44.14, 13.04, 33.66
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 43
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 532523 Biocon Ltd. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
02 Thu Apr 2026 352.55 342.35 to 367.75 -3.45% 1.98 times
01 Wed Apr 2026 365.15 362.00 to 371.65 1.19% 1.66 times
30 Mon Mar 2026 360.85 357.40 to 369.70 -2.5% 1.45 times
27 Fri Mar 2026 370.10 368.40 to 379.00 -2.53% 1.13 times
25 Wed Mar 2026 379.70 370.15 to 381.85 2.87% 1.13 times
24 Tue Mar 2026 369.10 367.10 to 377.20 0.48% 1.91 times
23 Mon Mar 2026 367.35 365.85 to 379.60 -3.56% 0.37 times
20 Fri Mar 2026 380.90 370.30 to 382.50 3.41% 0.91 times
19 Thu Mar 2026 368.35 366.45 to 379.40 -3.65% 0.26 times
18 Wed Mar 2026 382.30 376.90 to 386.00 1.19% 0.59 times
17 Tue Mar 2026 377.80 375.20 to 382.80 0.28% 0.59 times
16 Mon Mar 2026 376.75 369.20 to 387.40 -1.68% 0.99 times

Videos related to: 532523 announcements Biocon Ltd. announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

532523 announcements Biocon Ltd. announcements and dividends declared BSE

 

Back to top